# Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

> **NCT00482352** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 11196 (actual)

## Conditions studied

- Untreated Adult Acute Lymphoblastic Leukemia
- Untreated Childhood Acute Lymphoblastic Leukemia

## Interventions

- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00482352
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2012-04
- **Final completion:** 2023-06-30
- **Target enrollment:** 11196 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482352, "Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00482352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*